These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

749 related articles for article (PubMed ID: 26718593)

  • 1. Epidemiology of multiple sclerosis.
    Leray E; Moreau T; Fromont A; Edan G
    Rev Neurol (Paris); 2016 Jan; 172(1):3-13. PubMed ID: 26718593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geographic variations of multiple sclerosis in France.
    Fromont A; Binquet C; Sauleau EA; Fournel I; Bellisario A; Adnet J; Weill A; Vukusic S; Confavreux C; Debouverie M; Clerc L; Bonithon-Kopp C; Moreau T
    Brain; 2010 Jul; 133(Pt 7):1889-99. PubMed ID: 20551111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cost of multiple sclerosis in France].
    Fromont A; Lehanneur MN; Rollot F; Weill A; Clerc L; Bonithon Kopp C; Binquet C; Moreau T
    Rev Neurol (Paris); 2014; 170(6-7):432-9. PubMed ID: 24856285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of multiple sclerosis: insights to a causal cascade.
    Goodin DS
    Handb Clin Neurol; 2016; 138():173-206. PubMed ID: 27637959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental factors in multiple sclerosis.
    Ascherio A
    Expert Rev Neurother; 2013 Dec; 13(12 Suppl):3-9. PubMed ID: 24289836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender influence in EBV antibody response in multiple sclerosis patients from Kuwait.
    Al-Temaimi R; Alroughani R; Jacob S; Al-Mulla F
    J Neuroimmunol; 2015 Aug; 285():57-61. PubMed ID: 26198919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of multiple sclerosis in the Republic of Ireland: A prospective population-based study.
    O'Connell K; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2017 Apr; 13():75-80. PubMed ID: 28427707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in multiple sclerosis epidemiology and treatment response.
    Magyari M
    Dan Med J; 2016 Mar; 63(3):. PubMed ID: 26931196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and mortality of patients with multiple sclerosis in France in 2012: a study based on French health insurance data.
    Foulon S; Maura G; Dalichampt M; Alla F; Debouverie M; Moreau T; Weill A
    J Neurol; 2017 Jun; 264(6):1185-1192. PubMed ID: 28516332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The organisation of health care and epidemiology of multiple sclerosis in France].
    Debouverie M; Rumbach L; Clavelou P
    Rev Neurol (Paris); 2007 Jun; 163(6-7):637-45. PubMed ID: 17607182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of multiple sclerosis: insights to disease pathogenesis.
    Goodin DS
    Handb Clin Neurol; 2014; 122():231-66. PubMed ID: 24507521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological study of multiple sclerosis in La Rioja.
    Bártulos Iglesias M; Marzo Sola ME; Estrella Ruiz LA; Bravo Anguiano Y
    Neurologia; 2015; 30(9):552-60. PubMed ID: 24975346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender as a prognostic factor and its impact on the incidence of multiple sclerosis in Lorraine, France.
    Debouverie M
    J Neurol Sci; 2009 Nov; 286(1-2):14-7. PubMed ID: 19691994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
    Banwell B; Bar-Or A; Arnold DL; Sadovnick D; Narayanan S; McGowan M; O'Mahony J; Magalhaes S; Hanwell H; Vieth R; Tellier R; Vincent T; Disanto G; Ebers G; Wambera K; Connolly MB; Yager J; Mah JK; Booth F; Sebire G; Callen D; Meaney B; Dilenge ME; Lortie A; Pohl D; Doja A; Venketaswaran S; Levin S; Macdonald EA; Meek D; Wood E; Lowry N; Buckley D; Yim C; Awuku M; Cooper P; Grand'maison F; Baird JB; Bhan V; Marrie RA
    Lancet Neurol; 2011 May; 10(5):436-45. PubMed ID: 21459044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-specific environmental influences affecting MS development.
    Correale J; Balbuena Aguirre ME; Farez MF
    Clin Immunol; 2013 Nov; 149(2):176-81. PubMed ID: 23498776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on multiple sclerosis, its diagnosis and treatments.
    Cross AH; Cross KA; Piccio L
    Clin Chem Lab Med; 2012 Mar; 50(7):1203-10. PubMed ID: 22850053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The increasing incidence and prevalence of female multiple sclerosis--a critical analysis of potential environmental factors.
    Sellner J; Kraus J; Awad A; Milo R; Hemmer B; Stüve O
    Autoimmun Rev; 2011 Jun; 10(8):495-502. PubMed ID: 21354338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D and other environmental risk factors in Colombian patients with multiple sclerosis.
    Toro J; Reyes S; Díaz-Cruz C; Burbano L; Cuéllar-Giraldo DF; Duque A; Reyes-Mantilla MI; Torres C; Ríos J; Rivera JS; Cortés-Muñoz F; Patiño J; Noriega D
    Mult Scler Relat Disord; 2020 Jun; 41():101983. PubMed ID: 32086164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and natural history of multiple sclerosis: new insights.
    Kantarci O; Wingerchuk D
    Curr Opin Neurol; 2006 Jun; 19(3):248-54. PubMed ID: 16702830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of multiple sclerosis in Europe: a review.
    Koutsouraki E; Costa V; Baloyannis S
    Int Rev Psychiatry; 2010; 22(1):2-13. PubMed ID: 20233110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.